Dr. Tannie Huang, MD is an Adjunct Assistant Professor of Pediatrics for the Chobanian and Avedisian School of Medicine. Dr. Huang attend Harvard University, earning a degree in archaeology and obtained her medical degree from the University of South Carolina School of Medicine in 2005. She completed her fellowship training in pediatric hematology oncology at the University of California, San Francisco (UCSF). After her fellowship was completed, Dr. Huang continued practicing at UCSF for two years and joined The Permanente Medical Group in 2014. She is board certified in both General Pediatrics and Pediatric Hematology Oncology. Pediatric hematology oncology is a rapidly changing field, and Dr. Huang is committed to providing the best evidence-based medicine for her patients.
- Kaiser Permanente Santa Clara Medical Center
- University of South Carolina, MD
- Harvard University, BA
- Published on 11/5/2020
Wong JC, Perez-Mancera PA, Huang TQ, Kim J, Grego-Bessa J, Del Pilar Alzamora M, Kogan SC, Sharir A, Keefe SH, Morales CE, Schanze D, Castel P, Hirose K, Huang GN, Zenker M, Sheppard D, Klein OD, Tuveson DA, Braun BS, Shannon K. KrasP34R and KrasT58I mutations induce distinct RASopathy phenotypes in mice. JCI Insight. 2020 11 05; 5(21). PMID: 32990679.
- Published on 4/5/2019
Poulin EJ, Bera AK, Lu J, Lin YJ, Strasser SD, Paulo JA, Huang TQ, Morales C, Yan W, Cook J, Nowak JA, Brubaker DK, Joughin BA, Johnson CW, DeStefanis RA, Ghazi PC, Gondi S, Wales TE, Iacob RE, Bogdanova L, Gierut JJ, Li Y, Engen JR, Perez-Mancera PA, Braun BS, Gygi SP, Lauffenburger DA, Westover KD, Haigis KM. Tissue-Specific Oncogenic Activity of KRASA146T. Cancer Discov. 2019 06; 9(6):738-755. PMID: 30952657.
- Published on 10/9/2017
Maertens O, McCurrach ME, Braun BS, De Raedt T, Epstein I, Huang TQ, Lauchle JO, Lee H, Wu J, Cripe TP, Clapp DW, Ratner N, Shannon K, Cichowski K. A Collaborative Model for Accelerating the Discovery and Translation of Cancer Therapies. Cancer Res. 2017 Nov 01; 77(21):5706-5711. PMID: 28993414.
- Published on 10/31/2014
Burgess MR, Hwang E, Firestone AJ, Huang T, Xu J, Zuber J, Bohin N, Wen T, Kogan SC, Haigis KM, Sampath D, Lowe S, Shannon K, Li Q. Preclinical efficacy of MEK inhibition in Nras-mutant AML. Blood. 2014 Dec 18; 124(26):3947-55. PMID: 25361812.
- Published on 1/10/2013
Huang T, Mueller S, Rutkowski MJ, Han SJ, Bloch O, Barani IJ, Parsa AT, Chang SM. Multidisciplinary care of patients with brain tumors. Surg Oncol Clin N Am. 2013 Apr; 22(2):161-78. PMID: 23453330.